Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Olysio

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olysio was produced by Janssen.

Germany’s IQWiG denies Astellas’ incontinence drug

Germany’s IQWiG denies Astellas’ incontinence drug Olysio recommended in Germany. There was also positive news from IQWiG, however, with a recommendation for Janssen's hepatitis C treatment Olysio (simeprevir). ... However, the organisation could not establish the benefits of Olysio in patients with the

Medivir names new CEO

Medivir names new CEO His other roles include CEO of Pfizer's business in Sweden. Commenting on his new position, he highlighted Medivir's work with Johnson &Johnson to develop the hepatitis C treatment Olysio

Olysio leads charge at J&J but competition is on the way

Olysio leads charge at J&J but competition is on the way Sciences' Sovaldi (sofosbuvir), whose growth in the first few months has eclipsed even Olysio. ... year to $183m - the company is reluctant to speculate on Olysio's sales trajectory.

Janssen-backed report calls on governments to tackle hepatitis C

Janssen-backed report calls on governments to tackle hepatitis C Janssen's main drugs in the area are Incivo (telaprevir), which was launched in 2011, and Olysio (simeprevir), which was approved in the US in 2013 and in the EU earlier

Hepatitis C therapies: dawn of a new age

Hepatitis C therapies: dawn of a new age In 2013, the approvals of the HCV NS3/4A protease inhibitor simeprevir (Olysio; Medivir, Janssen) and the HCV NS5B inhibitor sofosbuvir (Sovaldi; Gilead) signalled the beginning of a new wave of

[ Previous 5 results ] 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....